Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA— 510(k) K190397
Substantially EquivalentImmunalysis Corporation
FDA 510(k) clearance K190397 for Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA, Substantially Equivalent on 2019-11-15. Applicant: Immunalysis Corporation.
Clearance details
- Applicant
- Immunalysis Corporation
- Product code
- Code QBK
- Advisory panel
- Clinical Toxicology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Pomona, CA, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.